{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:37:39Z","timestamp":1778629059196,"version":"3.51.4"},"reference-count":57,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.semnephrol.2011.06.003","type":"journal-article","created":{"date-parts":[[2011,8,13]],"date-time":"2011-08-13T10:43:49Z","timestamp":1313232229000},"page":"326-332","source":"Crossref","is-referenced-by-count":22,"title":["Focal and Segmental Glomerulosclerosis: Multiple Pathways Are Involved"],"prefix":"10.1016","volume":"31","author":[{"given":"Alain","family":"Meyrier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2011.06.003_bib1","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/ncpneph0025","article-title":"Mechanisms of disease: focal segmental glomerulosclerosis","volume":"1","author":"Meyrier","year":"2005","journal-title":"Nature Clin Pract Nephrol"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib2","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/sj.ki.5000160","article-title":"Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants","volume":"69","author":"Thomas","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib3","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2215\/CJN.04121206","article-title":"A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases","volume":"2","author":"Barisoni","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib4","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/sj.ki.5002222","article-title":"The spectrum of podocytopathies: a unifying view of glomerular diseases","volume":"71","author":"Wiggins","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib5","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/ki.2009.559","article-title":"Toward the development of podocyte-specific drugs","volume":"77","author":"Reiser","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib6","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1097\/01.ASN.0000145046.24268.0D","article-title":"Human podocytes possess a stretch-sensitive, Ca2+-activated K+ channel: potential implications for the control of glomerular filtration","volume":"5","author":"Morton","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib7","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1152\/physrev.00055.2006","article-title":"Properties of the glomerular barrier and mechanisms of proteinuria","volume":"88","author":"Haraldsson","year":"2008","journal-title":"Physiol Rev"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib8","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1681\/ASN.2004080720","article-title":"Genetic engineering of glomerular sclerosis in the mouse via control of onset and severity of podocyte-specific injury","volume":"16","author":"Matsusaka","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib9","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1681\/ASN.2005050488","article-title":"Podocyte hypertrophy, \u201dadaptation\u201d, and \u201cdecompensation\u201d associated with glomerular enlargement and glomerulosclerosis in the aging rat: prevention by calorie restriction","volume":"16","author":"Wiggins","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib10","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1681\/ASN.2005080841","article-title":"Role of podocytes in focal sclerosis: defining the point of no return","volume":"16","author":"Kretzler","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib11","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1038\/sj.ki.5001903","article-title":"Cellular focal segmental glomerulosclerosis: clinical and pathologic features","volume":"70","author":"Stokes","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib12","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1046\/j.1523-1755.2001.0590041498.x","article-title":"Obesity-related glomerulopathy: an emerging epidemic","volume":"59","author":"Kambahm","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib13","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1681\/ASN.2009040450","article-title":"Development of focal segmental glomerulosclerosis after anabolic steroid abuse","volume":"21","author":"Herlitz","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib14","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nrneph.2010.103","article-title":"Glomerular diseases: genetic causes and future therapeutics","volume":"6","author":"Chiang","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib15","doi-asserted-by":"crossref","first-page":"e6491","DOI":"10.1371\/journal.pone.0006491","article-title":"Identification of a putative network of actin-associated cytoskeletal proteins in glomerular podocytes defined by co-purified mRNAs","volume":"4","author":"Nabet","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib16","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.2215\/CJN.06910909","article-title":"Dystroglycan in the molecular diagnosis of the podocytopathies","volume":"4","author":"Kopp","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib17","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1681\/ASN.2007111172","article-title":"Disruption of myosin 1e promotes podocyte injury","volume":"20","author":"Krendel","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib18","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/ng.226","article-title":"MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis","volume":"40","author":"Kopp","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib19","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.semnephrol.2010.06.007","article-title":"MYH9 genetic variants associated with glomerular disease: what is the role for genetic testing?","volume":"30","author":"Kopp","year":"2010","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib20","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/ki.2010.251","article-title":"A risk allele for focal segmental glomerulosclerosis in African Americans is located within a region containing APOL1 and MYH9","volume":"78","author":"Genovese","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib21","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1517\/14656560902754029","article-title":"An update on the treatment options of focal segmental glomerulosclerosis","volume":"10","author":"Meyrier","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib22","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/ng.505","article-title":"Mutations in the formin protein INF2 causes focal segmental glomerulosclerosis","volume":"42","author":"Brown","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib23","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1681\/ASN.2007121292","article-title":"Young Investigator Award: TRP'ing into a new era for glomerular diseases","volume":"19","author":"Winn","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib24","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1681\/ASN.2008121226","article-title":"New insights into epithelial-mesenchymal transition in kidney","volume":"21","author":"Liu","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib25","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.trsl.2006.04.003","article-title":"Glomerular epithelial cells transform to myofibroblasts: early but not late removal of TGF-beta1 reverses transformation","volume":"148","author":"Sam","year":"2006","journal-title":"Transl Res"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib26","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrneph.2010.120","article-title":"Renal fibrosis: novel insights into mechanisms and therapeutic targets","volume":"6","author":"Boor","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib27","doi-asserted-by":"crossref","first-page":"F856","DOI":"10.1152\/ajprenal.00196.2005","article-title":"Podocytes are sensitive to fluid shear stress in vitro","volume":"291","author":"Friedrich","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib28","doi-asserted-by":"crossref","first-page":"F196","DOI":"10.1152\/ajprenal.00431.2005","article-title":"VEGF-C promotes survival in podocytes","volume":"291","author":"Foster","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib29","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1681\/ASN.2010080871","article-title":"VEGF receptors and glomerular function","volume":"21","author":"Parikh","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib30","doi-asserted-by":"crossref","first-page":"F1656","DOI":"10.1152\/ajprenal.00275.2009","article-title":"The balance of autocrine VEGF-A and VEGF-C determines podocyte survival","volume":"297","author":"M\u00fcller-Deile","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib31","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1038\/nm1667","article-title":"Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis","volume":"13","author":"Isermann","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib32","doi-asserted-by":"crossref","first-page":"F819","DOI":"10.1152\/ajprenal.90665.2008","article-title":"Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis","volume":"296","author":"Herbach","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib33","doi-asserted-by":"crossref","first-page":"F594","DOI":"10.1152\/ajprenal.00203.2009","article-title":"Impaired transcription factor interplay in addition to advanced glycation end products suppress podocalyxin expression in high glucose-treated human podocytes","volume":"297","author":"Drossopoulou","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib34","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0140-6736(74)91880-7","article-title":"Pathogenesis of lipoid nephrosis: a disorder of T cell function","volume":"2","author":"Shalhoub","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib35","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/ki.2009.204","article-title":"Treatment of focal segmental glomerulosclerosis with immunophilin modulation: when did we stop thinking about pathogenesis?","volume":"76","author":"Meyrier","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib36","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.2215\/CJN.06720810","article-title":"Posttransplant recurrence of primary glomerulonephritis","volume":"5","author":"Ponticelli","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib37","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1523-1755.2004.00776.x","article-title":"NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplantation recurrence","volume":"66","author":"Weber","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib38","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.semnephrol.2008.08.010","article-title":"Viruses and kidney disease: beyond HIV","volume":"26","author":"Waldman","year":"2008","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib39","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1097\/01.ASN.0000028249.06596.CF","article-title":"Molecular identification of SV40 infection in human subjects and possible association with kidney disease","volume":"13","author":"Li","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib40","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.2215\/CJN.01060307","article-title":"Parvovirus B19 and the kidney","volume":"2","author":"Waldman","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib41","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1038\/ki.2009.381","article-title":"Nephrin mutations cause childhood-and adult-onset focal segmental glomerulosclerosis","volume":"76","author":"Santin","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib42","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1038\/sj.ki.5002553","article-title":"Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome: workshop recommendations","volume":"72","author":"Cattran","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib43","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1517\/13543784.16.7.1099","article-title":"Tacrolimus in the treatment of idiopathic nephrotic syndrome","volume":"16","author":"Westhoff","year":"2007","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib44","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00467-007-0640-x","article-title":"Rituximab for refractory focal segmental glomerulosclerosis","volume":"23","author":"Nakayama","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib45","first-page":"3260","article-title":"Paradox of B cell-targeted therapies","volume":"118","author":"Kurosaki","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib46","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/sj.ki.5000317","article-title":"The effect of dexamethasone on defective nephrin transport caused by ER stress: a potential mechanism for the therapeutic action of glucocorticoids in the acquired glomerular diseases","volume":"69","author":"Fujii","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib47","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/sj.ki.5001655","article-title":"Direct effect of dexamethasone on human podocytes","volume":"70","author":"Xing","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib48","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1056\/NEJMcibr0806881","article-title":"Proteinuria and autoimmunity\u2014an overstated relationship?","volume":"359","author":"Mathieson","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib49","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nm.1857","article-title":"The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporin A","volume":"14","author":"Faul","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib50","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1097\/01.ASN.0000100145.27188.33","article-title":"Management of glomerular proteinuria: a commentary","volume":"14","author":"Wilmer","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib51","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/ncpneph0891","article-title":"Reversal of proteinuric renal disease and the emerging role of endothelin","volume":"4","author":"Barton","year":"2008","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib52","first-page":"800","article-title":"Recurrent glomerulonephritis after renal transplantation: an unsolved problem","volume":"3","author":"Golgert","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib53","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s00467-006-0361-6","article-title":"Recurrence of nephrotic syndrome\/focal segmental glomerulosclerosis following transplantation in children","volume":"22","author":"Fine","year":"2007","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib54","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1681\/ASN.2007121365","article-title":"Fidelity and evolution of recurrent FSGS in renal allografts","volume":"19","author":"Ijpelaar","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib55","doi-asserted-by":"crossref","first-page":"326","DOI":"10.2215\/CJN.03751106","article-title":"High sirolimus levels may induce focal segmental glomerulosclerosis de novo","volume":"2","author":"Fervenza","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib56","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1111\/j.1600-6143.2005.01112.x","article-title":"Preemptive plasmapheresis and recurrence of FSGS in high-risk renal transplantation recipients","volume":"5","author":"Gohh","year":"2005","journal-title":"Am J Transpl"},{"key":"10.1016\/j.semnephrol.2011.06.003_bib57","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002231","article-title":"Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis","volume":"3","author":"Fornoni","year":"2011","journal-title":"Sci Transl Med"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929511000647?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929511000647?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T15:30:07Z","timestamp":1543591807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929511000647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0270929511000647"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2011.06.003","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}